From the Design to the


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
13 05 2021
Historique:
pubmed: 5 5 2021
medline: 17 6 2021
entrez: 4 5 2021
Statut: ppublish

Résumé

The pharmacological inhibition of soluble epoxide hydrolase (sEH) is efficient for the treatment of inflammatory and pain-related diseases. Numerous potent sEH inhibitors (sEHIs) present adamantyl or phenyl moieties, such as the clinical candidates AR9281 or EC5026. Herein, in a new series of sEHIs, these hydrophobic moieties have been merged in a benzohomoadamantane scaffold. Most of the new sEHIs have excellent inhibitory activities against sEH. Molecular dynamics simulations suggested that the addition of an aromatic ring into the adamantane scaffold produced conformational rearrangements in the enzyme to stabilize the aromatic ring of the benzohomoadamantane core. A screening cascade permitted us to select a candidate for an

Identifiants

pubmed: 33945278
doi: 10.1021/acs.jmedchem.0c01601
pmc: PMC8634379
doi:

Substances chimiques

Enzyme Inhibitors 0
Epoxide Hydrolases EC 3.3.2.-
Adamantane PJY633525U

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5429-5446

Subventions

Organisme : NIEHS NIH HHS
ID : P42 ES004699
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK103616
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK107767
Pays : United States
Organisme : NIEHS NIH HHS
ID : R35 ES030443
Pays : United States

Références

Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8849-54
pubmed: 10430859
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
Xenobiotica. 1988 Oct;18(10):1109-18
pubmed: 3242307
Curr Protoc Toxicol. 2007;Chapter 4:Unit 4.23
pubmed: 23045145
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
J Chem Phys. 2007 Oct 21;127(15):155102
pubmed: 17949218
J Med Chem. 2012 Mar 8;55(5):1789-808
pubmed: 22168898
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
Annu Rev Pharmacol Toxicol. 2013;53:37-58
pubmed: 23020295
N Engl J Med. 2016 Nov 17;375(20):1972-1981
pubmed: 27959604
Chemistry. 2018 Aug 22;24(47):12254-12258
pubmed: 29633396
Drug Discov Today. 2015 Sep;20(9):1104-11
pubmed: 25931264
J Med Chem. 2021 Feb 25;64(4):1856-1872
pubmed: 33550801
Anal Biochem. 2007 May 15;364(2):204-12
pubmed: 17376394
Bioorg Med Chem. 2019 Oct 15;27(20):115078
pubmed: 31488357
Bioorg Med Chem. 2010 Jan 1;18(1):46-57
pubmed: 19954985
J Chem Theory Comput. 2020 Jul 14;16(7):4641-4654
pubmed: 32427471
PLoS One. 2014 Nov 17;9(11):e113019
pubmed: 25402489
J Clin Pharmacol. 2012 Mar;52(3):319-28
pubmed: 21422238
Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):757-71
pubmed: 19505190
Biochem Pharmacol. 2015 Dec 15;98(4):718-31
pubmed: 26494425
J Chem Theory Comput. 2011 Mar 8;7(3):625-632
pubmed: 21516178
Gastroenterology. 2013 Jun;144(6):1252-61
pubmed: 23622135
Mol Pharmacol. 2015 Aug;88(2):281-90
pubmed: 25993999
Gene. 2013 Sep 10;526(2):61-74
pubmed: 23701967
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W270-7
pubmed: 21624888
Bioorg Chem. 2018 Feb;76:510-527
pubmed: 29310082
Bioorg Med Chem Lett. 2018 Jul 15;28(13):2302-2313
pubmed: 29803731
Bioorg Med Chem. 2014 Apr 15;22(8):2427-34
pubmed: 24656800
Br J Clin Pharmacol. 2016 May;81(5):971-9
pubmed: 26620151
Pancreas. 2017 Apr;46(4):482-488
pubmed: 28196021
Pancreas. 2015 Nov;44(8):1195-210
pubmed: 26465949
J Chem Theory Comput. 2014 Nov 11;10(11):5047-5056
pubmed: 25400521
Bioorg Med Chem. 2015 Jan 15;23(2):290-6
pubmed: 25515953
J Med Chem. 2020 Sep 10;63(17):9237-9257
pubmed: 32787085
J Med Chem. 2021 Jan 14;64(1):184-215
pubmed: 33369424
J Comput Chem. 2011 Jul 30;32(10):2149-59
pubmed: 21541955
Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):83-91
pubmed: 24015667
Eur J Pharmacol. 2013 Jan 30;700(1-3):93-101
pubmed: 23276668
Bioorg Med Chem. 2014 May 1;22(9):2678-83
pubmed: 24698811
J Med Chem. 2007 Aug 9;50(16):3825-40
pubmed: 17616115
Bioorg Med Chem. 2012 Jan 15;20(2):942-8
pubmed: 22178660
Annu Rev Biophys Biomol Struct. 1999;28:155-79
pubmed: 10410799

Auteurs

Sandra Codony (S)

Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, Barcelona 08028, Spain.

Carla Calvó-Tusell (C)

CompBioLab Group, Departament de Química and Institut de Química Computacional i Catàlisi (IQCC), Universitat de Girona, C/ Maria Aurèlia Capmany 69, Girona 17003, Spain.

Elena Valverde (E)

Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, Barcelona 08028, Spain.

Sílvia Osuna (S)

CompBioLab Group, Departament de Química and Institut de Química Computacional i Catàlisi (IQCC), Universitat de Girona, C/ Maria Aurèlia Capmany 69, Girona 17003, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain.

Christophe Morisseau (C)

Department of Entomology and Nematology and Comprehensive Cancer Center, University of California Davis, One Shields Avenue, Davis 95616, California, United States.

M Isabel Loza (MI)

Drug Screening Platform/Biofarma Research Group, CIMUS Research Center. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica, University of Santiago de Compostela (USC), Santiago de Compostela 15782, Spain.

José Brea (J)

Drug Screening Platform/Biofarma Research Group, CIMUS Research Center. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica, University of Santiago de Compostela (USC), Santiago de Compostela 15782, Spain.

Concepción Pérez (C)

Institute of Medicinal Chemistry, Spanish National Research Council (CSIC), C/Juan de la Cierva 3, Madrid 28006, Spain.

María Isabel Rodríguez-Franco (MI)

Institute of Medicinal Chemistry, Spanish National Research Council (CSIC), C/Juan de la Cierva 3, Madrid 28006, Spain.

Javier Pizarro-Delgado (J)

Pharmacology Section. Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, Barcelona 08028, Spain.
Spanish Biomedical Research Center in Diabetes and Associated Metabolic Diseases (CIBERDEM)-Instituto de Salud Carlos III, Madrid 28029, Spain.
Pediatric Research Institute-Hospital Sant Joan de Déu, Esplugues de Llobregat 08950, Spain.

Rubén Corpas (R)

Institute of Biomedical Research of Barcelona (IIBB), CSIC and IDIBAPS, Barcelona 08036, Spain.
CIBER Epidemiology and Public Health (CIBERESP)-Instituto de Salud Carlos III, Madrid 28029, Spain.

Christian Griñán-Ferré (C)

Pharmacology Section. Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, Barcelona 08028, Spain.

Mercè Pallàs (M)

Pharmacology Section. Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, Barcelona 08028, Spain.

Coral Sanfeliu (C)

Institute of Biomedical Research of Barcelona (IIBB), CSIC and IDIBAPS, Barcelona 08036, Spain.
CIBER Epidemiology and Public Health (CIBERESP)-Instituto de Salud Carlos III, Madrid 28029, Spain.

Manuel Vázquez-Carrera (M)

Pharmacology Section. Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, Barcelona 08028, Spain.
Spanish Biomedical Research Center in Diabetes and Associated Metabolic Diseases (CIBERDEM)-Instituto de Salud Carlos III, Madrid 28029, Spain.
Pediatric Research Institute-Hospital Sant Joan de Déu, Esplugues de Llobregat 08950, Spain.

Bruce D Hammock (BD)

Department of Entomology and Nematology and Comprehensive Cancer Center, University of California Davis, One Shields Avenue, Davis 95616, California, United States.

Ferran Feixas (F)

CompBioLab Group, Departament de Química and Institut de Química Computacional i Catàlisi (IQCC), Universitat de Girona, C/ Maria Aurèlia Capmany 69, Girona 17003, Spain.

Santiago Vázquez (S)

Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, Barcelona 08028, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH